الملخص
The use of anti-epidermal growth factor receptor antibodies, such as cetuximab, is a standard part of the management of metastatic colorectal and head and neck cancers, as they inhibit tumor proliferation. Their side effects include cutaneous complications such as skin rash, hypertrichosis, and male pattern alopecia. We report a case of a middle-aged woman who developed hypertrichosis following six cycles of cetuximab treatment with a hirsutism-related hormone profile.
الكلمات المفتاحية
بيانات النشر
- المعرّف الرقمي
- 10.5001/omj.2025.29
- المجلة
- مجلة عُمان الطبية, 41(1)
- الناشر
- المجلس العُماني للاختصاصات الطبية
- وصول مفتوح
- وصول مفتوح ذهبي
- الترخيص
- CC BY-NC 4.0
اقتبس هذه المقالة
APA 7
Abu Omar, R., Al Ghoche, A., & Al-Moundhri, M. (2026). Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma. Oman Medical Journal, 41(1). https://doi.org/10.5001/omj.2025.29
MLA 9
Abu Omar, Rami, et al. "Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma." Oman Medical Journal, vol. 41, no. 1, 2026. https://doi.org/10.5001/omj.2025.29.
شيكاغو (المؤلف–التاريخ)
Abu Omar, Rami, Ahmad Al Ghoche, and Mansour Al-Moundhri. 2026. "Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma." Oman Medical Journal 41 (1). https://doi.org/10.5001/omj.2025.29.
هارفارد
Abu Omar, R., Al Ghoche, A. and Al-Moundhri, M. (2026) 'Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma', Oman Medical Journal, 41(1). doi:10.5001/omj.2025.29.
فانكوفر
Abu Omar R, Al Ghoche A, Al-Moundhri M. Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma. Oman Medical Journal. 2026;41(1). doi:10.5001/omj.2025.29
IEEE
R. Abu Omar, A. Al Ghoche, and M. Al-Moundhri, "Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma," Oman Medical Journal, vol. 41, no. 1, 2026, doi: 10.5001/omj.2025.29.